Biologic medicines sales distribution by treatment costs in Canada 2018

Biologics sales distribution by treatment costs in Canada in 2018*

Loading statistic...
Download
Show detailed source information?
Register for free
Already a member?
Log in
Sources

Use Ask Statista Research Service

Release date

May 2020

Region

Canada

Survey time period

2018

Supplementary notes

* Annual treatment costs are based on average annual per beneficiary costs for public and private plans.
** Expensive drugs for rare diseases (EDRDs) are defined as medicines having an FDA or EMA orphan designation and an annual treatment cost greater than $100,000 for nononcology medicines or $7,500 per 28- day course of treatment for oncology medicines.

Citation formats
Statista Accounts: Access All Statistics. Starting from $2,388 USD / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Starter Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$199 USD / Month *
Professional Account
Full access

Business Solutions including all features.

* Prices do not include sales tax.

Statistics on " Medical biotech industry "

Other statistics that may interest you Medical biotech industry

Global overview

7

U.S. and European landscape

6

Focus: U.S. companies

8

Research & development

6

Products

5

Funding/M&A/IPOs

6

Focus: RNA/mRNA

4

Further related statistics

10
Statista Accounts: Access All Statistics. Starting from $2,388 USD / Year
Learn more about how Statista can support your business.